Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/durvalumab-plus-bcg-earns-fda-nod-bladder-cancer-2026a1000hv5?src=rss

Author :

Publish date : 2026-05-28 20:20:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

FDA OKs Immunotherapy-BCG Combo for High-Risk Bladder Cancer

FDA Panel Backs New COVID Vaccines Aimed at Dominant Strain

Related Posts

Is Microdosing Accutane Safe? Dermatologist Weighs In

Patient-Reported QoL Offers Prognostic Information in AML

Gas-X Recall; MASLD and Alzheimer’s Mortality; Counties Without a Gastroenterologist

They Told Families to ‘Eat Real Food.’ Now They May Cut the Produce Benefit.

Foot Doc Sues HHS for $50M; Upside-Down Heart Valve Suit; Doc Gets 40 Years

Scientists Call Charges Against NIH Virologists ‘Chilling’

Is Microdosing Accutane Safe? Dermatologist Weighs In

Patient-Reported QoL Offers Prognostic Information in AML

Gas-X Recall; MASLD and Alzheimer’s Mortality; Counties Without a Gastroenterologist

They Told Families to ‘Eat Real Food.’ Now They May Cut the Produce Benefit.

Foot Doc Sues HHS for $50M; Upside-Down Heart Valve Suit; Doc Gets 40 Years

Scientists Call Charges Against NIH Virologists ‘Chilling’

Make the Diagnosis: Chest Pain, Dyspnea, Palpitations, and More: What’s Her Diagnosis?

Why did it take so long for me to be diagnosed?

Categories

Archives